Researchers have developed the EXOSense technology to capture tiny particles, called extracellular vesicles, from biofluids ...

Researchers from the University at Buffalo and Roswell Park Comprehensive Cancer Center are developing an artificial ...

Researchers are advancing AI’s role in healthcare by integrating human-relevant preclinical models with computational frameworks to improve cancer immunotherapy predictions, while also expanding AI’s ...

At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...

UB and Roswell Park researchers created MIRACLE, an AI tool that combines clinical data, CT imaging and LLM insights to ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

Rectal cancer deaths among millennials under 45 are rising 2–3 times faster than colon cancer. Doctors urge early symptom ...

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.